VBWG

9 related results for Diabetes


Managing CV Risk in Diabetes: Setting More Aggressive Goals to Meet a Growing Crisis

The evolving diabetes epidemic is raising concern over the adverse long-term effect on cardiovascular (CV) disease.

ADOPT: A Diabetes Outcome Progression Trial

View/Download individual slides (15 Slides)

RIO-Diabetes trial: Rimonabant In Obesity

View/Download individual slides (13 Slides)

PROactive: The first prospective clinical outcomes trial of PPAR g agonists

Compared with the general population, persons with diabetes have a twofold greater absolute risk of cardiovascular (CV) disease.

HOPE-TOO: Extended use of ACEI reduces CV risk and new diabetes, independent of baseline risk

Results from large clinical trials provide evidence that angiotensin-converting enzyme inhibitors (ACEIs) are effective in the treatment of cardiovascular (CV) disease.

Role of lipid lowering for prevention of cardiovascular events in type 2 diabetes

Cardiovascular (CV) disease is the primary complication and cause of death in people with type 2 diabetes mellitus, 1 accounting for nearly two thirds of deaths.

Vascular Biology in Clinical Practice © Vol. 5, No. 2

Managing lipids in patients with diabetes: New evidence from vascular biology and clinical trials

This monograph, Managing lipids in patients with diabetes: New evidence from vascular biology and clinical trials , is offered as part of a series of continuing medical education programs from the University of Florida College of Medicine.

Vascular Biology in Clinical Practice © Vol. 2, No. 3

Diabetes and cardiovascular disease: The emerging role of the endothelium and implications for treatment

This monograph Diabetes and cardiovascular disease: The emerging role of the endothelium and implications for treatment.